SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Macquarie Analyst Comments on ResMed’s Maintained Revenue Guidance

ResMed maintained its annual revenue guidance at US$5.75 billion to US$5.85 billion. A Macquarie analyst said the decision suggests underlying operational improvement.

RMD

Related stories